Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes. (17th January 2022)

• Record Type: Journal Article
• Authors: Fu, Yuanyuan; Hu, Ling; Ren, Hong-Wei; Zuo, Yi; Chen, Shaoqiu; Zhang, Qiu-Shi; Shao, Chen; Ma, Yao; Wu, Lin; Hao, Jun-Jie; Wang, Chuan-Zhen; Wang, Zhanwei; Yanagihara, Richard; Deng, Youping
• Other Names: Merlotti Daniela Academic Editor.
• Is Part Of: International journal of endocrinology. Volume 2022(2022)
• Publication Date: 2022-01-17
• Subjects: Endocrinology -- Periodicals; Endocrinology; Endocrinology -- Periodicals; Endocrine System Diseases -- Periodicals; Periodicals; 616.4
• DOI: 10.1155/2022/9322332
• Languages: English
• ISSNs: 1687-8337

Abstract

Abstract : Background . Type 2 diabetes (T2D) as a worldwide chronic disease combined with the COVID-19 pandemic prompts the need for improving the management of hospitalized COVID-19 patients with preexisting T2D to reduce complications and the risk of death. This study aimed to identify clinical factors associated with COVID-19 outcomes specifically targeted at T2D patients and build an individualized risk prediction nomogram for risk stratification and early clinical intervention to reduce mortality. Methods . In this retrospective study, the clinical characteristics of 382 confirmed COVID-19 patients, consisting of 108 with and 274 without preexisting T2D, from January 8 to March 7, 2020, in Tianyou Hospital in Wuhan, China, were collected and analyzed. Univariate and multivariate Cox regression models were performed to identify specific clinical factors associated with mortality of COVID-19 patients with T2D. An individualized risk prediction nomogram was developed and evaluated by discrimination and calibration. Results . Nearly 15% (16/108) of hospitalized COVID-19 patients with T2D died. Twelve risk factors predictive of mortality were identified. Older age (HR = 1.076, 95% CI = 1.014–1.143, p = 0.016 ), elevated glucose level (HR = 1.153, 95% CI = 1.038–1.28, p = 0.0079 ), increased serum amyloid A (SAA) (HR = 1.007, 95% CI = 1.001–1.014, p = 0.022 ), diabetes treatment with only oral diabetes medication (HR = 0.152, 95%CI = 0.032–0.73, p = 0.0036 ), and oral medication plus insulin (HR = 0.095, 95%CI = 0.019–0.462, p = 0.019 ) were independent prognostic factors. A nomogram based on these prognostic factors was built for early prediction of 7-day, 14-day, and 21-day survival of diabetes patients. High concordance index (C-index) was achieved, and the calibration curves showed the model had good prediction ability within three weeks of COVID-19 onset. Conclusions . By incorporating specific prognostic factors, this study provided a user-friendly graphical risk prediction tool for clinicians to quickly identify high-risk T2D patients hospitalized for COVID-19.